Pharmacologic Thromboprophylaxis in Medical Inpatients
Christophe Marti, Marc Righini, Grégoire Le Gal, Laura Girardi, Helia Robert-Ebadi, Christophe Combescure, Jean-Luc Reny, Marc Blondon · 2026
Read Pharmacologic Thromboprophylaxis in Medical Inpatients by Christophe Marti, Marc Righini, Grégoire Le Gal, Laura Girardi, Helia Robert-Ebadi, Christophe Combescure, Jean-Luc Reny, Marc Blondon (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13179560.txt.
Description
Christophe Marti and co-authors pool trials of blood-thinning drugs to stop clots in medical inpatients in a 2026 review. Such drugs are in wide use, yet their net gain for clots that cause symptoms was in doubt. The team searched four databases through January 2026 for fair trials in adults with acute medical illness.
Trials compared three drug families with no care or a dummy pill. Pairs of reviewers screened and scored each trial on their own. Pooled risk ratios then weighed clots that showed symptoms against bleeding harm, so wards can judge the trade-off of each regimen.
Catalog record
| CREATOR | Christophe Marti, Marc Righini, Grégoire Le Gal, Laura Girardi, Helia Robert-Ebadi, Christophe Combescure, Jean-Luc Reny, Marc Blondon |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |